Nancy D. Bone

2.4k total citations
37 papers, 1.9k citations indexed

About

Nancy D. Bone is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Nancy D. Bone has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 15 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Nancy D. Bone's work include Chronic Lymphocytic Leukemia Research (33 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Nancy D. Bone is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Nancy D. Bone collaborates with scholars based in United States, United Kingdom and France. Nancy D. Bone's co-authors include Neil E. Kay, Diane F. Jelinek, Tait D. Shanafelt, Renee C. Tschumper, Gordon W. Dewald, Susan M. Geyer, Yean Kee Lee, Ann K. Strege, Timothy G. Call and Clive S. Zent and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Mayo Clinic Proceedings.

In The Last Decade

Nancy D. Bone

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy D. Bone United States	20	1.1k	768	764	567	360	37	1.9k
Michele Dal Bo Italy	26	850 0.8×	642 0.8×	578 0.8×	597 1.1×	112 0.3×	86	1.9k
Charla Secreto United States	16	475 0.4×	449 0.6×	339 0.4×	561 1.0×	138 0.4×	40	1.3k
Akintunde Akinleye United States	11	248 0.2×	343 0.4×	298 0.4×	660 1.2×	105 0.3×	13	1.5k
Ji Yuan Wu United States	21	803 0.7×	168 0.2×	190 0.2×	712 1.3×	908 2.5×	44	2.1k
Heather G. Jørgensen United Kingdom	27	1.6k 1.5×	253 0.3×	146 0.2×	1.0k 1.8×	2.3k 6.4×	61	3.2k
Giulia Perrone Italy	20	248 0.2×	267 0.3×	207 0.3×	1.3k 2.3×	1.5k 4.2×	53	2.4k
Yongping Song China	16	223 0.2×	440 0.6×	170 0.2×	866 1.5×	90 0.3×	28	1.7k
Diana Cirstea United States	22	168 0.2×	188 0.2×	210 0.3×	1.6k 2.9×	894 2.5×	80	2.4k
Miriam Farina Italy	10	286 0.3×	110 0.1×	203 0.3×	837 1.5×	51 0.1×	20	1.5k

Countries citing papers authored by Nancy D. Bone

Since Specialization

Citations

This map shows the geographic impact of Nancy D. Bone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy D. Bone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy D. Bone more than expected).

Fields of papers citing papers by Nancy D. Bone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy D. Bone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy D. Bone. The network helps show where Nancy D. Bone may publish in the future.

Co-authorship network of co-authors of Nancy D. Bone

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy D. Bone. A scholar is included among the top collaborators of Nancy D. Bone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy D. Bone. Nancy D. Bone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Yean Kee, Nancy D. Bone, Ann K. Strege, et al.. (2011). chronic lymphocytic leukemia green tea component, epigallocatechin-3-gallate (EGCG), in B-cell VEGF receptor phosphorylation status and apoptosis is modulated by a.

Nowakowski, Grzegorz S., James D. Hoyer, Tait D. Shanafelt, et al.. (2009). Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 27(11). 1844–1849. 56 indexed citations

Zent, Clive S., Charla Secreto, Betsy LaPlant, et al.. (2008). Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab. Leukemia Research. 32(12). 1849–1856. 74 indexed citations

Shanafelt, Tait D., Susan M. Geyer, Nancy D. Bone, et al.. (2008). CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. British Journal of Haematology. 140(5). 537–546. 118 indexed citations

Mukherjee, Priyabrata, Resham Bhattacharya, Nancy D. Bone, et al.. (2007). Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. Journal of Nanobiotechnology. 5(1). 4–4. 165 indexed citations

Martin, William G., Roshini S. Abraham, Tait D. Shanafelt, et al.. (2007). Serum-free light chain—a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Translational research. 149(4). 231–235. 50 indexed citations

Geyer, Susan M., Amy J. Johnson, Diane F. Jelinek, et al.. (2007). Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. Leukemia Research. 31(12). 1737–1740. 10 indexed citations

Kay, Neil E., Tait D. Shanafelt, Ann K. Strege, et al.. (2007). Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”. Leukemia Research. 31(7). 899–906. 64 indexed citations

Shanafelt, Tait D., Nancy D. Bone, Susan M. Geyer, et al.. (2006). Prognostic Importance of CD49d Expression in Chronic Lymphocytic Leukemia.. Blood. 108(11). 2776–2776. 1 indexed citations

10.

Zent, Clive S., Nancy D. Bone, Timothy G. Call, et al.. (2006). Alemtuzumab and Rituximab for Therapy of Patents with Early Stage High Risk CLL: Report of a Planned Interim Analysis.. Blood. 108(11). 2829–2829. 4 indexed citations

11.

Kay, Neil E., Susan M. Geyer, Timothy G. Call, et al.. (2006). Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia. Blood. 109(2). 405–411. 220 indexed citations

12.

Kay, Neil E., Nancy D. Bone, Yean Kee Lee, et al.. (2005). A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells. Leukemia Research. 29(9). 1009–1018. 12 indexed citations

13.

Ghobrial, Irene M., Nancy D. Bone, Mary Stenson, et al.. (2004). Expression of the Chemokine Receptors CXCR4 and CCR7 and Disease Progression in B-Cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Mayo Clinic Proceedings. 79(3). 318–325. 68 indexed citations

14.

Naumovski, Louie, Nancy D. Bone, Mint Sirisawad, et al.. (2004). Motexafin Gadolinium, a Redox Mediator, Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells and Is Additive or Synergistic with Fludarabine.. Blood. 104(11). 4799–4799. 1 indexed citations

15.

Kay, Neil E., Ann K. Strege, Tait D. Shanafelt, Nancy D. Bone, & Yean Kee Lee. (2004). CLL B Cell Interaction with Bone Biopsy Generated Marrow Stromal Elements Enhances Their Apoptosis Resistance in Association with an Angiogenic Switch.. Blood. 104(11). 1914–1914. 1 indexed citations

16.

Chandra, Joya, Jennifer S. Hackbarth, Son B. Le, et al.. (2003). Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood. 102(13). 4512–4519. 58 indexed citations

17.

Jelinek, Diane F., Renee C. Tschumper, Susan M. Geyer, et al.. (2001). Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia. British Journal of Haematology. 115(4). 854–861. 164 indexed citations

18.

Kay, Neil E., et al.. (2001). Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8⁺ T cells from B‐CLL patients: impact on clonal B‐cell apoptosis. British Journal of Haematology. 112(3). 760–767. 43 indexed citations

19.

Kay, Neil E., Traci Leong, Robert A. Kyle, et al.. (1999). Altered T cell Repertoire Usage in CD4 and CD8 Subsets of Multiple Myeloma Patients, a Study of the Eastern Cooperative Oncology Group (E9487). Leukemia & lymphoma. 33(1-2). 127–133. 26 indexed citations

20.

Kay, Neil E., Traci Leong, Nancy D. Bone, et al.. (1998). T‐helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93. British Journal of Haematology. 100(3). 459–463. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact